The Fas counterattack: Fas-mediated T cell killing by colon cancer expressing Fas ligand

Journal of Experimental Medicine

Volumn 184, Issue 3, 1996, Pages 1075-1082

  O'Connell, Joe ^a   O'Sullivan, Gerald C ^a   Collins, J Kevin ^a   Shanahan, Fergus ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b University Hospital ^*  (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MONOCLONAL ANTIBODY;

APOPTOSIS; ARTICLE; CELL KILLING; COLON CANCER; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; GENE DISRUPTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LIGAND BINDING; LYMPHOCYTE ACTIVATION; MEDIATOR RELEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029808372     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.3.1075     Document Type: Article

References (41)

1. Broaddus, R.R., M.J. Wargovich, and G.A. Castro. 1994. Early stages of 1,2-dimethylhydrazine-induced colon carcinogenesis suppress immune-regulated ion transport of mouse distal colon. Cancer Res. 54:5930-5936.
2. O'Mahony, A.M., G.C. O'Sullivan, J. O'Connell, T.G. Cotter, and J.K. Collins. 1993. An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J. Immunol. 151:4847-4856.
3. Yagita, M., A. Seppo, O. Renkonen, and E. Saksela. 1993. Deacetylase activity of human tumor cells producing immunosuppressive aminosugars: its possible role in resistance to cell-mediated cytotoxicity. Cancer Res. 53:5600-5604.
4. Li, R., D. Gage, and S. Ladisch. 1993. Biosynthesis and shedding of murine lymphoma gangliosides. Biochim. Biophys. Acta. 1170:283-290.
5. Bergelson, L.D. 1993. Gangliosides and antitumor immunity. Clin. Invest. 71:590-594.
6. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1456.
7. Yonehara, S., Y. Nishimura, S. Kishil, M. Yonehara, K. Takazawa, T. Tamatani, and A. Ishii. 1994. Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. Int. Immunol. 6:1849-1856.
8. Alderson, M.R., T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
9. Daniel, P.T., and P.H. Krammer. 1994. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J. Immunol. 152:5624-5632.
10. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA. 91:4185-4189.
11. Fisher, G.H., F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middleton, A.Y. Lin, W. Strober, M.J. Lenardo, and J.M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 81:935-946.
12. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I.A. Roberts, K.M. Debatin, A. Fischer, and J.P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (Wash. DC). 268:1347-1349.
13. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today. 16:39-43.
14. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R.C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature (Lond.). 377:630-632.
15. Griffith, T.S., T. Brunner, S.M. Fletcher, D.R. Green, and T.A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science (Wash. DC). 270: 1189-1192.
16. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ogha et al. 1996. Fas ligand in human serum. Nat. Med. 2:317-322.
17. Debatin, K.M., and P.H. Krammer. 1995. Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a bcl-2 independent anti-apoptotic program. Leukemia. 9: 815-820.
18. Shima, Y., N. Nishimoto, A. Ogata, Y. Fujii, K. Yoshizaki, and T. Kishimoto. 1995. Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood. 85:757-764.
19. Owen-Schaub, L.B., R. Radinsky, E. Kruzel, K. Berry, and S. Yonehara. 1994. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 54:1580-1586.
20. Wright, S.C., J. Zhong, and J.W. Larrick. 1994. Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J. 8: 654-660.
21. Wright, S.C., J. Zhong, H. Zheng, and J.W. Larrick. 1993. Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J. 7:1045-1051.
22. Gibellini, D., A. Caputo, C. Celeghini, A. Bassini, M. La Placa, S. Capitani, and G. Zauli. 1995. Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. Br J. Haematol. 89:24-33.
23. Copeland, K.F., A.G. Haaksma, J. Goudsmit, P.H. Krammer, and J.L. Heeney. 1994. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res. Hum. Retroviruses, 10:1259-1268.
24. Collins, J.K., A. O'Mahony, D. Morrissey, F. O'Brien, A. Corbett, M. O'Donoghue, and G.C. O'Suilivan. 1992. Evaluation of newly established cell lines as models to study growth, invasion and metastatic spread in esophageal cancer. Fibrinolysis. 6:83-98.
25. Cascino, I., G. Fiucci, G. Papoff, and G. Ruberti. 1995. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 154:2706-2713.
26. Degols, G., J.-P. Leonetti, N. Mechti, and B. Lebleu. 1991. Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene. Nucleic Acids Res. 19:945-948.
27. Capaccioli, S., G. Di Pasquale, E. Mini, T. Mazzei, and A. Quattrone. 1993. Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem. Biophys. Res. Commun. 197:818-825.
28. Matzinger, P. 1991. The JAM test: a simple assay for DNA fragmentation and cell death. J. Immunol. Methods. 145:185-192.
29. Weller, M., K. Frei, P. Groscurth, P.H. Krammer, Y. Yonekawa, and A. Fontana. 1994. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94: 954-964.
30. Owen-Schaub, L.B., W. Zhang, J.C. Cusack, L.S. Angelo, S.M. Santee, T. Fujiwara, J.A. Roth, A.B. Deisseroth, W.W. Zhang, E. Kruzel et al. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15:3032-3040.
31. Quirk, S.M., R.G. Cowan, S.G. Joshi, and K.P. Henrikson. 1995. Fas antigen-mediated apoptosis in human granulosa/luteal cells. Biol. Reprod. 52:279-287.
32. Matsue, H., H. Kobayashi, T. Hosokawa, T. Akitaya, and A. Ohkawara. 1995. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes. Arch. Dermatol. Res. 287:315-320.
33. Sayama, K., S. Yonehara, Y. Watanabe, and Y. Miki. 1994. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J. Invest. Dermatol. 103:330-334.
34. Weller, M., U. Malipiero, A. Aguzzi, J.C. Reed, and A. Fontana. 1995. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J. Clin. Invest. 95:2633-2643.
35. Itoh, N., S. Yonehara, S.-I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:233-243.
36. Weller, M., U. Malipiero, A. Rensing-Ehl, P.J. Barr, and A. Fontana. 1995. Fas/APO-1 gene transfer for human malignant glioma. Cancer Res. 55:2936-2944.
37. Mountz, J.D., J. Wu, J. Cheng, and T. Zhou. 1994. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum. 37:1415-1420.
38. Cheng, J., T. Zhou, C. Liu, J.P. Shapiro, M.J. Brauer, M.C. Kiefer, P.J. Barr, and J.D. Mountz. 1994. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science (Wash. DC). 263:1759-1762.
39. Jaattela, M., M. Benedict, M. Tewari, J.A. Shayman, and V.M. Dixit. 1995. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phosphohpase A2 in breast carcinoma cells. Oncogene. 10:2297-2305.
40. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:621-627.
41. Yoshino, T., E. Kondo, L. Cao, K. Takahashi, K. Hayashi, S. Nomura, and T. Akagi. 1994. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood. 83:1856-1861.